Clinical trial
Randomized Controlled Trial to Reduce Surgical Site Infections in Breast Cancer Surgery With Clorhexidine Gluconate Securement Dressing (Tegaderm CHG)
NCT03229824 is registered in ClinicalTrials.gov with National Institute of Cancerología as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Controlled Trial to Reduce Surgical Site Infections in Breast Cancer Surgery With Clorhexidine Gluconate Securement Dressing (Tegaderm CHG)
- Lead sponsor
- National Institute of Cancerología
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 3, 2016
- Completion date
- May 30, 2018
- Enrollment
- 116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer